ESG

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.

Posting sector-leading 6.5% organic growth, the testing and certification giant validates its LEAP | 28 strategy with strong profits and a new buyback.

A leading Indian tour company is breaking barriers by training women as long-distance chauffeurs, a move redefining tourism and empowering communities.

The global logistics giant didn't just win awards; it validated a strategy that merges sustainability with financial performance and investor trust.

The healthcare specialist reported a staggering 2025 net loss due to a write-down, but projects 30% revenue growth fueled by new contracts.

Shipping giant Matson posts strong Q4 results, buoyed by e-commerce and a stable US-China trade deal, and charts a course for growth with a $425M investment.

Archrock crushes profit estimates and hikes its dividend, signaling strong confidence as it positions to power the soaring energy demands of LNG and AI.

The biotech firm secures major funding to push its promising head and neck cancer drug, ficerafusp alfa, toward regulatory approval and commercial launch.

Fueled by policy incentives and strong demand, First Solar reports robust 2025 growth and accelerates its US factory expansion, cementing its market leadership.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

The beloved Marin grocer announces its third store, creating 200+ jobs and serving as a key player in the Northgate Mall's ambitious transformation.

A Florida jury found Publix 100% liable for a fall that led to three spinal surgeries for a young mother, rejecting the company's $600k offer.

Nabsys's electronic genome mapping reveals how rogue genetic elements damage our DNA, opening new frontiers in understanding cancer and neurodegeneration.

A landmark partnership embeds mental wellness into youth programs, aiming to reach 355,000 teens and redefine what it means to be prepared for the future.

Pioneering clean beauty brand Indie Lee launches an affordable new line, Indie Lee Botanicals, exclusively at Whole Foods Market, making quality skincare accessible.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

In a strategic move to tackle space debris, Applied Aerospace & Defense buys Vestigo, whose Spinnaker drag sails offer a solution to new regulations.

A planned reverse merger for promising vaccine developer SVF Vaccines has collapsed after Nasdaq rejected the deal, leaving its lead investor scrambling.

With 1,000 employers on board, TIAA and Nuveen's lifetime income funds are bringing pension-like certainty back to the 401(k) for over 1 million workers.